ALPS Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $121K | Buy |
|
|||||
|
2024
Q4 | $143K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $358K | Buy |
|
|||||
|
2023
Q2 | $539K | Buy |
|
|||||
|
2023
Q1 | $355K | Sell |
|
|||||
|
2022
Q4 | $712K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $796K | Buy |
|
|||||
|
2018
Q2 | $896K | Buy |
|
|||||
|
2018
Q1 | $725K | Buy |
|
|||||
|
2017
Q4 | $843K | Buy |
|
|||||
|
2017
Q3 | $762K | Buy |
|
|||||
|
2017
Q2 | $654K | Buy |
|
|||||
|
2017
Q1 | $668K | Sell |
|
|||||
|
2016
Q4 | $663K | Buy |
|